Received Mar 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | D252F | IM / UN |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | 2 | Y003144 | IM / UN |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 2 | LG5577 | IM / UN |
Patient received two courses of 2 month vaccines. The two month vaccines administered were PedvaxHIB, Prevnar and Pediarix. All doses were the same lot number on administration on 2/21/25 and 3/5/25. The patient tolerated the vaccines well and did not demonstrates signs or symptoms of a reaction. Patient was discharged from NICU on 3/6/25.
Prematurity, Anemia of Prematurity
Grade 2 bilateral intraventricular hemorrhage
Poly-Vi-Sol with Iron
N/A
N/A